Crizotinib as first line therapy for advanced ALK-positive non-small cell lung cancers

Por Chuang, Jody C., Neal, Joel W.
Publicado no Transl Lung Cancer Res (2015)

Concordant and Discordant EGFR Mutations in Patients with Multifocal Adenocarcinomas: Implications for EGFR Targeted Therapy

Por Chuang, Jody C., Shrager, Joseph B., Wakelee, Heather A., Neal, Joel W.
Publicado no Clin Ther (2016)

ERBB2-mutated metastatic non-small cell lung cancer: response and resistance to targeted therapies

Por Chuang, Jody C., Stehr, Henning, Liang, Ying, Das, Millie, Huang, Jane, Diehn, Maximilian, Wakelee, Heather A., Neal, Joel W.
Publicado no J Thorac Oncol (2017)

S110, a 5-aza-2’-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth

Por Chuang, Jody C., Warner, Steven L., Vollmer, David, Vankayalapati, Hariprasad, Redkar, Sanjeev, Bearss, David J., Qiu, Xiangning, Yoo, Christine B., Jones, Peter A.
Publicado em 2010

Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice

Por Yoo, Christine B., Chuang, Jody C., Byun, Hyang-Min, Egger, Gerda, Yang, Allen S., Dubeau, Louis, Long, Tiffany, Laird, Peter W., Marquez, Victor E., Jones, Peter A.
Publicado no Cancer Prev Res (Phila) (2008)

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as se...

Por Gubens, Matthew A., Chuang, Jody C., Akerley, Wallace, Langer, Corey J., Clément-Duchêne, Christelle, San Pedro-Salcedo, Melanie, Colevas, A. Dimitrios, Dragnev, Konstantin, Socinski, Mark A., Wakelee, Heather A.
Publicado no J Thorac Dis (2018)